Ö. Besci Et Al. , "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys," PEDIATRIC CARDIOLOGY , 2023
Besci, Ö. Et Al. 2023. Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys. PEDIATRIC CARDIOLOGY .
Besci, Ö., Akçura, Y. D., Acinikli, K., Kağızmanlı, G. A., Demir, K., Böber, E., ... Kır, M.(2023). Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys. PEDIATRIC CARDIOLOGY .
Besci, ÖZGE Et Al. "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys," PEDIATRIC CARDIOLOGY , 2023
Besci, ÖZGE Et Al. "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys." PEDIATRIC CARDIOLOGY , 2023
Besci, Ö. Et Al. (2023) . "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys." PEDIATRIC CARDIOLOGY .
@article{article, author={ÖZGE BESCİ Et Al. }, title={Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys}, journal={PEDIATRIC CARDIOLOGY}, year=2023}